Analysis of JnJ COVID booster data by USFDA scientists raises red flags Ruchika Sharma14 Oct 2021 12:30 PM ISTUS: U.S. Food and Drug Administration scientists said on Wednesday they did not receive enough data in time to do their own analysis of Johnson &...
Single shot Sputnik Light shows 70 percent efficacy against Covid Delta variant: RDIF Ruchika Sharma14 Oct 2021 11:30 AM ISTMoscow: The Russian Direct Investment Fund (RDIF, Russia's sovereign wealth fund) and Gamaleya National Research Center of Epidemiology and...
Moderna did not meet all criteria for Covid-19 boosters, says USFDA staff Ruchika Sharma14 Oct 2021 10:00 AM ISTUS: Scientists at the U.S. Food and Drug Administration said on Tuesday that Moderna Inc had not met all of the agency's criteria to support use of...
Health Bulletin 13/October/2021 Roshni Dhar13 Oct 2021 7:00 PM ISTHere are the top Health Stories of the dayUnion Health Minister steps in to probe Rs 1.8 crore COVID bill levied by MAX HOSPITAL SAKETUnion Health...
JnJ, Moderna COVID vaccine third dose efficacy to be evaluated by USFDA this week MD Bureau13 Oct 2021 2:00 PM ISTWashington: The US Food and Drug Administration is expected to evaluate the efficacy of Moderna and Johnson & Johnson's third dose of Covid...
Biological E seeks DCGI nod for phase-3 trial of Corbevax as booster dose Ruchika Sharma13 Oct 2021 11:41 AM ISTNew Delhi: Hyderabad-based pharmaceutical company Biological E has sought permission from India's drug regulator to conduct the phase-3 clinical trial...
CDSCO panel emergency use nod to Covaxin for children aged 2-18 years Ruchika Sharma12 Oct 2021 3:23 PM ISTNew Delhi: An expert panel of India's Central Drug Authority has recommended granting emergency use authorisation to Bharat Biotech's Covaxin...
India allows export of Hetero Biopharma produced Sputnik Light Ruchika Sharma11 Oct 2021 2:09 PM ISTNew Delhi: The government has permitted the export of Russia's single-dose Covid-19 vaccine Sputnik Light domestically produced here as the jab has...
Covaxin trial data in children submitted to CDSCO Ruchika Sharma7 Oct 2021 2:26 PM ISTHyderabad: Bharat Biotech, which completed the Phase 2/3 trials of COVID-19 vaccine Covaxin for use in children under 18 years of age, has submitted...
Sweden halts Moderna Covid vaccine for people under 30 MD Bureau7 Oct 2021 9:00 AM ISTStockholm: Sweden has stopped administering the Moderna Covid-19 vaccine Spikevax to people under 30 years of age due to a suspected connection...
DCGI nod to phase III trials of Cadila Healthcare two-dose COVID vaccine Ruchika Sharma6 Oct 2021 4:05 PM ISTNew Delhi: Drug firm Cadila Healthcare on Tuesday said it has received permission from the Indian drug regulator for conducting phase III trials for...
AstraZeneca seeks USFDA authorization for Covid-19 Prophylaxis drug AZD7442 Ruchika Sharma6 Oct 2021 2:13 PM ISTUK: AstraZeneca has submitted a request to the US Food and Drug Administration (USFDA) for an Emergency Use Authorization (EUA) for AZD7442, its...
